Related Experiment Video
Updated: Aug 30, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
The J-curve in hypertension
142 Harefield, Long Melford, Suffolk CO10 9DE, United Kingdom. johndtl@aol.com
Insights
The J-curve effect in blood pressure management is often due to reverse causality. For most hypertensive patients, lowering diastolic blood pressure (DBP) to the low 80s is beneficial and safe, but not essential.
Area of Science:
- Cardiology
- Hypertension Management
- Clinical Trials
Background:
- The J-curve phenomenon, relating blood pressure to adverse events, has been debated for 25 years.
- Observational studies have confounded the J-curve issue, with reverse causality often implicated.
- Underlying conditions like poor cardiac function or arterial stiffness can cause both low blood pressure and increased event risk.
Purpose of the Study:
- To clarify the J-curve debate using data from the prospective, randomized Hypertension Optimal Treatment (HOT) study.
- To determine the optimal diastolic blood pressure (DBP) targets for hypertensive patients.
- To investigate the J-curve relationship in patients with and without coronary artery disease.
Main Methods:
- Analysis of the full publication data from the Hypertension Optimal Treatment (HOT) study.
- Prospective, randomized trial design to minimize bias.
- Evaluation of cardiovascular and noncardiovascular events in relation to treated diastolic blood pressure (DBP).
Main Results:
- For non-ischemic hypertensive subjects, lowering DBP to the low 80s mm Hg is beneficial; further reduction is safe but unproductive.
- In patients with coronary artery disease, a J-curve relationship exists between treated DBP and myocardial infarction risk.
- No significant J-curve was observed for stroke risk in patients with coronary artery disease.
Conclusions:
- The HOT study provides clear evidence on blood pressure targets, resolving much of the J-curve debate.
- For most hypertensive patients, DBP can be safely lowered to the low 80s mm Hg.
- In patients with coronary artery disease, maintaining DBP above the low 80s mm Hg is prudent to avoid myocardial infarction risk.
Abstract:
The J-curve debate has continued for 25 years. Dependency upon observational and retrospective studies has confused the issue; only the full publication of data from the prospective, randomized Hypertension Optimal Treatment (HOT) study has thrown genuine light on the problem. Many examples of the J-curve relationship between blood pressure and cardiovascular/noncardiovascular events are due to reverse causality, where underlying disease (eg, poor left ventricular function, poor general health, poorly compliant/stiff arteries) is the cause of both the low blood pressure and the increased risk of both cardiovascular and noncardiovascular events. The J-curve in patients with stiff arteries (wide pulse pressure) may be exacerbated by treatment. From the full publication of the HOT study database it is now reasonable to conclude that for nonischemic hypertensive subjects the therapeutic lowering of diastolic blood pressure (DBP) to the low 80s mm Hg is beneficial, but it is safe (though unproductive) to go lower. However, in the presence of coronary artery disease (limited coronary flow reserve) there is a J-curve relationship between treated DBP and myocardial infarction, but not for stroke. In such high-risk (for myocardial infarction) cases it would be prudent to avoid lowering DBP to below the low 80s mm Hg.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications